SEC Filings

SEC Filings

Filing date	Description	Form	Company	View
May 22, 2020	Statement of changes in beneficial ownership of securities	4	Surface Oncology	0001209191-20-031786.pdf 0001209191-20-031786.rtf 0001209191-20-031786.xls View HTML
May 20, 2020	Report of unscheduled material events or corporate event	8-K	Surface Oncology	0001564590-20-026253.pdf 0001564590-20-026253.rtf 0001564590-20-026253.xls View HTML
May 15, 2020	Report of unscheduled material events or corporate event	8-K	Surface Oncology	0001564590-20-025639.pdf 0001564590-20-025639.rtf 0001564590-20-025639.xls View HTML
May 14, 2020	Report of unscheduled material events or corporate event	8-K	Surface Oncology	0001564590-20-025265.pdf 0001564590-20-025265.rtf 0001564590-20-025265.xls View HTML
May 12, 2020	Report of unscheduled material events or corporate event	8-K	Surface Oncology	0001564590-20-024463.pdf 0001564590-20-024463.rtf 0001564590-20-024463.xls View HTML
May 12, 2020	Quarterly report which provides a continuing view of a company's financial position	10-Q	Surface Oncology	0001564590-20-024469.pdf 0001564590-20-024469.rtf 0001564590-20-024469.xls EX-101.INS - XBRL INSTANCE DOCUMENT View HTML
Apr 24, 2020	Report of unscheduled material events or corporate event	8-K	Surface Oncology	0001564590-20-018288.pdf 0001564590-20-018288.rtf 0001564590-20-018288.xls View HTML
Apr 22, 2020	Official notification to shareholders of matters to be brought to a vote ("Proxy")	DEF 14A	Surface Oncology	0001564590-20-017796.pdf 0001564590-20-017796.rtf 0001564590-20-017796.xls View HTML
Apr 22, 2020	Additional proxy soliciting materials - definitive	DEFA14A	Surface Oncology	0001564590-20-017800.pdf 0001564590-20-017800.rtf View HTML
Mar 17, 2020	Report of unscheduled material events or corporate event	8-K	Surface Oncology	0001193125-20-075500.pdf 0001193125-20-075500.rtf 0001193125-20-075500.xls View HTML

Data provided by Kaleidoscope.